title: Fatal interstitial lung disease after erlotinib administration in a patient with radiation fibrosis.
authors.affiliation: Department of Internal Medicine, Dong-A University College of Medicine, Busan, Korea.
authors.forename: Soo-Jung
authors.initials: SJ
authors.lastname: Um
authors.forename: Soo-Keol
authors.initials: SK
authors.lastname: Lee
authors.forename: Doo Kyung
authors.initials: DK
authors.lastname: Yang
authors.forename: Choonhee
authors.initials: C
authors.lastname: Son
authors.forename: Mee Sook
authors.initials: MS
authors.lastname: Roh
authors.forename: Ki Nam
authors.initials: KN
authors.lastname: Kim
authors.forename: Ki-Nam
authors.initials: KN
authors.lastname: Lee
authors.forename: Pil Jo
authors.initials: PJ
authors.lastname: Choi
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D000069347:Erlotinib Hydrochloride; D017809:Fatal Outcome; D006801:Humans; D017563:Lung Diseases, Interstitial / Q000139:chemically induced*; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D047428:Protein Kinase Inhibitors / Q000009:adverse effects*; D011799:Quinazolines / Q000009:adverse effects*; D017564:Radiation Pneumonitis / Q000150:complications*
chemical_list: D047428:Protein Kinase Inhibitors; D011799:Quinazolines; D000069347:Erlotinib Hydrochloride